Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure

NCT05805579 is registered in ClinicalTrials.gov with Javier Lázaro as lead sponsor.

NCT NCT05805579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05805579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure
Lead sponsor
Javier Lázaro
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
June 20, 2021
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, pneumonia, viral, respiratory failure